Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study

@inproceedings{Ofstad2013Interleukin6AA,
  title={Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and B{\ae}rum Cardiovascular Diabetes (ABCD) cohort study},
  author={Anne Pernille Ofstad and Lars Gullestad and Elsa Orvik and Svend Aakhus and Knut Endresen and Thor Ueland and P{\aa}l Aukrust and Morten Wang Fagerland and K{\aa}re I Birkeland and Odd Erik Johansen},
  booktitle={Cardiovascular diabetology},
  year={2013}
}
BACKGROUND Novel and robust cardiovascular (CV) markers are needed to improve CV morbidity and mortality risk prediction in type 2 diabetes (T2D). We assessed the long term predictive value of 4 novel CV risk markers for major CV events and mortality. METHODS We included patients with T2D who had cytokines (interleukin [IL]-6 and activin A [actA]), a maximum stress ECG test (evaluated by the normalization pattern in early recovery phase) and echocardiography (evaluated by a measure of the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Determinants of mortality in patients with type 2 diabetes: a review

Reviews in Endocrine and Metabolic Disorders • 2016
View 2 Excerpts
Highly Influenced

Obesity and stroke: Can we translate from rodents to patients?

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism • 2016

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Activin A and cardiovascular disease in type 2 diabetes mellitus.

Diabetes & vascular disease research • 2012
View 3 Excerpts

Similar Papers

Loading similar papers…